BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30440067)

  • 1. [Development and Results of Transcatheter and Surgical Aortic Valve Replacement in Germany 2014 and 2015].
    Stachon P; Kaier K; Zirlik A; Bothe W; Zehender M; Bode C; von Zur Mühlen C
    Dtsch Med Wochenschr; 2018 Nov; 143(23):e206-e212. PubMed ID: 30440067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-Specific Differences in Outcome of Transcatheter or Surgical Aortic Valve Replacement.
    Kaier K; von Zur Mühlen C; Zirlik A; Schmoor C; Roth K; Bothe W; Hehn P; Reinöhl J; Zehender M; Bode C; Stachon P
    Can J Cardiol; 2018 Aug; 34(8):992-998. PubMed ID: 30056851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-hospital mortality in propensity-score matched low-risk patients undergoing routine isolated surgical or transfemoral transcatheter aortic valve replacement in 2014 in Germany.
    Frerker C; Bestehorn K; Schlüter M; Bestehorn M; Hamm CW; Möllmann H; Katus HA; Kuck KH
    Clin Res Cardiol; 2017 Aug; 106(8):610-617. PubMed ID: 28283745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-hospital outcomes after transcatheter or surgical aortic valve replacement in younger patients less than 75 years old: a propensity-matched comparison.
    Eggebrecht H; Bestehorn K; Rassaf T; Bestehorn M; Voigtländer T; Fleck E; Schächinger V; Schmermund A; Mehta RH
    EuroIntervention; 2018 May; 14(1):50-57. PubMed ID: 29488888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally Invasive Versus Transcatheter and Surgical Aortic Valve Replacement: A Propensity Matched Study.
    Terwelp MD; Thourani VH; Zhao Y; Balan P; Loghin C; Ocazionez D; Estrera A; Hoffmann CT; Babaliaros VC; Lamelas J; Nguyen TC
    J Heart Valve Dis; 2017 Mar; 26(2):146-154. PubMed ID: 28820543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: A single center 20-year experience.
    Garcia S; Kelly R; Mbai M; Gurevich S; Oestreich B; Yannopoulos D; Adabag S
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):390-398. PubMed ID: 29316204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
    Seppelt PC; Zappel J; Weiler H; Mas-Peiró S; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):54-64. PubMed ID: 31033152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve).
    Généreux P; Cohen DJ; Williams MR; Mack M; Kodali SK; Svensson LG; Kirtane AJ; Xu K; McAndrew TC; Makkar R; Smith CR; Leon MB
    J Am Coll Cardiol; 2014 Mar; 63(11):1100-9. PubMed ID: 24291283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of transfemoral TAVR versus surgical aortic valve replacement.
    Arora S; Vaidya SR; Strassle PD; Misenheimer JA; Rhodes JA; Ramm CJ; Wheeler EN; Caranasos TG; Cavender MA; Vavalle JP
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):806-812. PubMed ID: 29068166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
    Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008-2015.
    Stachon P; Kaier K; Heidt T; Bothe W; Zirlik A; Zehender M; Bode C; von Zur Mühlen C
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):810-816. PubMed ID: 31165569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Study of TAVR versus SAVR in Moderate and High-Risk Surgical Patients: Hospital Outcome and Midterm Results.
    Abdelgawad AME; Hussein MA; Naeim H; Abuelatta R; Alghamdy S
    Heart Surg Forum; 2019 Aug; 22(5):E331-E339. PubMed ID: 31596707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct Comparison of Feasibility and Safety of Transfemoral Versus Transaortic Versus Transapical Transcatheter Aortic Valve Replacement.
    Arai T; Romano M; Lefèvre T; Hovasse T; Farge A; Le Houerou D; Hayashida K; Watanabe Y; Garot P; Benamer H; Unterseeh T; Bouvier E; Morice MC; Chevalier B
    JACC Cardiovasc Interv; 2016 Nov; 9(22):2320-2325. PubMed ID: 27884356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Length of Stay and Discharge Disposition After Transcatheter Versus Surgical Aortic Valve Replacement in the United States.
    Arora S; Strassle PD; Kolte D; Ramm CJ; Falk K; Jack G; Caranasos TG; Cavender MA; Rossi JS; Vavalle JP
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e006929. PubMed ID: 30354596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.
    Conte JV; Hermiller J; Resar JR; Deeb GM; Gleason TG; Adams DH; Popma JJ; Yakubov SJ; Watson D; Guo J; Zorn GL; Reardon MJ
    Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):321-330. PubMed ID: 29195573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial.
    Kapadia SR; Huded CP; Kodali SK; Svensson LG; Tuzcu EM; Baron SJ; Cohen DJ; Miller DC; Thourani VH; Herrmann HC; Mack MJ; Szerlip M; Makkar RR; Webb JG; Smith CR; Rajeswaran J; Blackstone EH; Leon MB;
    J Am Coll Cardiol; 2018 Nov; 72(20):2415-2426. PubMed ID: 30442284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.
    Mack MJ; Leon MB; Smith CR; Miller DC; Moses JW; Tuzcu EM; Webb JG; Douglas PS; Anderson WN; Blackstone EH; Kodali SK; Makkar RR; Fontana GP; Kapadia S; Bavaria J; Hahn RT; Thourani VH; Babaliaros V; Pichard A; Herrmann HC; Brown DL; Williams M; Akin J; Davidson MJ; Svensson LG;
    Lancet; 2015 Jun; 385(9986):2477-84. PubMed ID: 25788234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement.
    Gleason TG; Schindler JT; Adams DH; Reardon MJ; Kleiman NS; Caplan LR; Conte JV; Deeb GM; Hughes GC; Chenoweth S; Popma JJ
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):85-96. PubMed ID: 27085389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Outcomes of Surgical and Transcatheter Aortic Valve Replacement for Aortic Stenosis in Nonagenarians.
    Zack CJ; Al-Qahtani F; Kawsara A; Al-Hijji M; Amin AH; Alkhouli M
    Am J Cardiol; 2017 Mar; 119(6):893-899. PubMed ID: 28061996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and Its Consequences After Surgical Versus Transcatheter Aortic Valve Replacement.
    Uhle F; Castrup C; Necaev AM; Grieshaber P; Lichtenstern C; Weigand MA; Böning A
    Artif Organs; 2018 Feb; 42(2):E1-E12. PubMed ID: 29226341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.